Navigation Links
Primary snoring in children impacts cardiovascular functioning
Date:6/11/2008

WESTCHESTER, Ill. Primary snoring in children may have an impact on cardiovascular functioning equivalent to that of moderate obstructive sleep apnea (OSA), according to a research abstract that will be presented Wednesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).

The study, authored by Angela Jackman and colleagues at the University of Melbourne and Monash University, Melbourne, Victoria, Australia, focused on 40 children who were referred for clinical assessment of a sleep-related breathing disorder and matched controls. Overnight polysomnography was performed, and heart rate and heart rate variability data from the total sleep period and from periods of uninterrupted sleep were analyzed. The subjects were grouped by clinical diagnosis: primary snoring, mild OSA, moderate OSA, severe OSA, and controls.

According to the results, significant overall differences were found in heart rate over the total sleep period and during stable sleep, whereby heart rate was highest in severe OSA, followed by primary snoring, moderate OSA, mild OSA, and controls. In time domain analyses, heart rate variability was significantly lower in primary snoring than in controls.

Primary snoring in children has traditionally been considered benign, in part because some children grow out of the condition without intervention, said Jackman. Mounting evidence now suggests, however, that this condition can impact cognition, behavior, and academic performance. Furthermore, our current preliminary findings concur with emerging evidence that primary snoring in children may also impact heart function. To the best of our knowledge, ours is the first study to compare the effects of varying severities of sleep-related breathing disorders on cardiovascular control and to suggest that children with primary snoring may be just as affected as children with more severe sleep-related breathing disorders (such as obstr
'/>"/>

Contact: Kathleen McCann
kmccann@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life
2. Aflac to be Primary Sponsor of Carl Edwards and the No. 99 Ford Fusion
3. Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
4. ACP says major system reforms needed to improve the state of primary care medicine in the US
5. Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers
6. Providence Saint Joseph Medical Named LA Countys Third Primary Stroke Center
7. Cardinal Health, ClearCount Medical Solutions Sign Primary Distribution Agreement for RFID-Enabled Sponge Counting, Detection System
8. One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines
9. ‘15by2015’ - A Campaign to Strengthen Primary Healthcare Around the World
10. An efficient response in primary care would reduce the use of hospitals by elderly people
11. Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Childrens Hospital at Stanford
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Its Time for More Moms to Breast Feed U S Officials Say 54480 1Its Time for More Moms to Breast Feed U S Officials Say 54480 2Its Time for More Moms to Breast Feed U S Officials Say 54480 3Little safe haven for sexually assaulted LGBTQ victims 54475 1Little safe haven for sexually assaulted LGBTQ victims 54475 2Little safe haven for sexually assaulted LGBTQ victims 54475 3Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 1Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 2Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 3